Severe Immune-Related Cutaneous Vasculitis Induced by Osimertinib. acmcr [Internet]. 2022 Jul. 12 [cited 2026 Sep. 11];6(4):524-7. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22639